跳至主要内容
临床试验/CTRI/2024/04/065336
CTRI/2024/04/065336尚未招募Unknown

Efficacy and Safety of the Topical Naftifine 2% Therapy versus Topical Luliconazole 1% Therapy in Patients with Localized Tinea Corporis in a Tertiary Care Centre - NI

DR R SUGANYA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients above the age of 18 years of either sex who were clinically and mycologically diagnosed of a case of localized dermatophytosis were included in the study.

排除标准

  • Patients with extensive dermatophytosis, other forms of tinea infections
  • Superadded bacterial infection
  • Immunocompromised patients
  • Dermatitis such as contact dermatitis, atopic dermatitis, psoriasis, other skin diseases
  • Use of corticosteroids in the last 4 weeks.
  • Pregnant and lactating mothers
  • Patients with a history of hypersensitivity to azole antifungals
  • Patients who received topical antifungal within 1 week before baseline visit and patients who received systemic antifungals within 4 weeks before baseline were excluded from the study.

研究者

发起方
DR R SUGANYA

相似试验